Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California. Show more
Location: 1800 Aston Avenue, Carlsbad, CA, 92008, United States | Website: https://carlsmed.com | Industry: Health Information Services | Sector: Healthcare
Market Cap
367.2M
52 Wk Range
$11.55 - $17.19
Previous Close
$13.50
Open
$13.85
Volume
49,526
Day Range
$13.28 - $14.14
Enterprise Value
269.5M
Cash
115.4M
Avg Qtr Burn
-6.965M
Insider Ownership
42.83%
Institutional Own.
38.81%
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
